DOTmed June 4, 2024
Philips has debuted two new AI applications for cardiovascular ultrasound designed to help clinicians identify and analyze disease faster and with less variability.
The FDA-cleared applications include an automated tool for segmental wall motion scoring of the heart to identify coronary artery disease and software that performs automated 3D quantification of mitral regurgitation volumes for patients with heart valve disease.
The tools also identify the best images from the exam to quantify and can provide support for clinical decision making.
The applications are integrated into Philips’ EPIQ CVx and Affiniti CVx ultrasound systems.
The release of this technology comes at a time when clinicians are seeing patient volumes increase, along with staffing shortages caused by retirement and the physically demanding...
Today's Sponsors
Today's Sponsor